In vivo autoimmune CAR-T race grows as two RNA startups enter the clinic

Two new startups have begun testing their in vivo CAR-T therapies for autoimmune disease in people. China-based Immorna recently treated a systemic sclerosis patient with an in vivo CAR-T therapy, and the patient’s peripheral B ...